Providing Market Intelligence for 40 Years

In The News

How Will We Search For TV Shows In The Future?

Traditional TV providers struggle to remain relevant to the adults of the future. Research from Parks Associates, organizer of the conference, shows that young adults (“millennials”) have grown up with streaming video and don’t have the same relationship to traditional TV. Almost a quarter of millennials (23%) have no pay TV services. Consider that in 2020 one in three adults will be a millennial. While they may watch video on phones, tablets, and laptops, eschewing big screen TVs, it’s likely that their choice of device will change as they start families in the future. What won’t change is their view on how they receive TV. Increasingly, they don’t relate to the ABC, NBC, CBS model of linear TV. Netflix, Hulu, and Amazon are becoming their broadcast networks.

From the article "How Will We Search For TV Shows In The Future?" by Barb Gonzalez.
 

Previously In The News

AT&T kills Plenti loyalty program but touts ongoing Thanks campaign

Parks Associates reported last year that 60% of respondents in a survey valued a rewards program for being a loyal customers, third only to the ability to roll over unused data (66%) and free access t...

One in five US subscribers now ‘dissatisfied’ with pay TV service

Some 20% of US pay TV subscribers are now dissatisfied with their pay TV service, according to research from Parks Associates. The future represents a 100% increase since 2013, according to Parks....

AT&T gooses $45 prepaid plan with cheaper iPhones

And, as a recent report from Parks Associates noted, consumers are increasingly drawn to the simplified pricing offers in prepaid. The firm said that “currently postpaid carriers are starting to explo...

Morning Read: Pharma Changes Afoot As Valeant Courts A New CEO And Novartis U.S. Head Exits

Less than half of caregivers with a smartphone use apps aimed at caregivers, according to a report by Parks Associates. — MobiHealthNews From the article "Morning Read: Pharma Changes Afoot As Vale...